PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Medical College (SHMC), Fudan University, Shanghai, China.\', \'National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.\', \'Biomedical Research Institute of Advaccine (BRIA), Advaccine Biopharmaceutics (Suzhou) Co. LTD, Suzhou City, Jiangsu.\', \'Key Laboratory of Human Disease Comparative Medicine, Chinese Ministry of Health, Beijing Key Laboratory for Animal Models of Emerging and Reemerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College (PUMC), Beijing, China.\', \'Inovio Pharmaceuticals, Plymouth Meeting, PA, USA.\', \'The Wistar Institute, Philadelphia, PA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/21645515.2021.2016201
?:hasPublicationType
?:journal
  • Human vaccines & immunotherapeutics
is ?:pmid of
?:pmid
?:pmid
  • 35061975
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Comparison of Wild Type DNA Sequence of Spike Protein from SARS-CoV-2 with Optimized Sequence on The Induction of Protective Responses Against SARS-Cov-2 Challenge in Mouse Model.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all